Forkhead box O1 and muscle RING finger 1 protein expression in atrophic and hypertrophic denervated mouse skeletal muscle

Journal of Molecular Signaling

Volumn 9, Issue 1, 2014, Pages

  Fjällström, Ann Kristin ^a   Evertsson, Kim ^a   Norrby, Marlene ^a   Tågerud, Sven ^a  

^a LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Acetylation; Atrophy; Cytosolic fraction; Denervation; Forkhead box O; Hypertrophy; MuRF1; Nuclear fraction; Phosphorylation; Skeletal muscle

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR O1; MUSCLE RING FINGER 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENERVATION; GASTROCNEMIUS MUSCLE; HEMIDIAPHRAGM; MALE; MOUSE; MUSCLE MASS; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN ACETYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; WESTERN BLOTTING;

EID: 84907392088     PISSN: None     EISSN: 17502187     Source Type: Journal    
DOI: 10.1186/1750-2187-9-9     Document Type: Article

References (53)

1. Spargo E, Pratt OE, Daniel PM. Metabolic functions of skeletal muscles of man, mammals, birds and fishes: a review. J R Soc Med 1979, 72:921-925. 1437224, 399625.
2. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 2013, 280:4294-4314. 10.1111/febs.12253, 23517348.
3. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412. 10.1016/S0092-8674(04)00400-3, 3619734, 15109499.
4. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I, Ezaki O. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 2004, 279:41114-41123. 10.1074/jbc.M400674200, 15272020.
5. Obsil T, Obsilova V. Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 2008, 27:2263-2275. 10.1038/onc.2008.20, 18391969.
6. Zhao Y, Wang Y, Zhu WG. Applications of post-translational modifications of FoxO family proteins in biological functions. J Mol Cell Biol 2011, 3:276-282. 10.1093/jmcb/mjr013, 21669942.
7. Daitoku H, Sakamaki J, Fukamizu A. Regulation of FoxO transcription factors by acetylation and protein-protein interactions. Biochim Biophys Acta 1813, 2011:1954-1960.
8. Calnan DR, Brunet A. The FoxO code. Oncogene 2008, 27:2276-2288. 10.1038/onc.2008.21, 18391970.
9. Vogt PK, Jiang H, Aoki M. Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 2005, 4:908-913. 10.4161/cc.4.7.1796, 15917664.
10. Huang HJ, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci 2007, 120:2479-2487. 10.1242/jcs.001222, 17646672.
11. Bodine SC, Latres E, Baumhueter S, Lai VKM, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na EQ, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708. 10.1126/science.1065874, 11679633.
12. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004, 18:39-51. 10.1096/fj.03-0610com, 14718385.
13. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol-Endocrinol Metabol 2004, 287:E591-E601.
14. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 2005, 280:2737-2744. 10.1074/jbc.M407517200, 15550386.
15. Sacheck JM, Hyatt JPK, Raffaello A, Jagoe RT, Roy RR, Edgerton VR, Lecker SH, Goldberg AL. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. Faseb J 2007, 21:140-155.
16. Foletta VC, White LJ, Larsen AE, Leger B, Russell AP. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch 2011, 461:325-335. 10.1007/s00424-010-0919-9, 21221630.
17. Llano-Diez M, Gustafson AM, Olsson C, Goransson H, Larsson L. Muscle wasting and the temporal gene expression pattern in a novel rat intensive care unit model. BMC Genomics 2011, 12:602. 10.1186/1471-2164-12-602, 3266306, 22165895.
18. Furuyama T, Kitayama K, Yamashita H, Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 2003, 375:365-371. 10.1042/BJ20030022, 1223677, 12820900.
19. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/PI3K/Akt pathway prevents short article expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004, 14:395-403. 10.1016/S1097-2765(04)00211-4, 15125842.
20. Waddell DS, Baehr LM, van den Brandt J, Johnsen SA, Reichardt HM, Furlow JD, Bodine SC. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am J Physiol Endocrinol Metab 2008, 295:E785-E797. 10.1152/ajpendo.00646.2007, 2652500, 18612045.
21. Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP. Akt signalling through GSK-3 beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol-London 2006, 576:923-933.
22. Tzivion G, Dobson M, Ramakrishnan G. FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 1813, 2011:1938-1945.
23. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, Fukamizu A. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci U S A 2005, 102:11278-11283. 10.1073/pnas.0502738102, 1183558, 16076959.
24. Sola OM, Martin AW. Denervation hypertrophy and atrophy of the hemidiaphragm of the rat. Am J Physiol 1953, 172:324-332.
25. Feng TP, Lu DX. New lights on the phenomenon of transient hypertrophy in the denervated hemidiaphragm of the rat. Sci Sin 1965, 14:1772-1784.
26. Gutmann E, Hanikova M, Hajek I, Klicpera M, Syrovy I. The postdenervation hypertrophy of the diaphragm. Physiol Bohemoslov 1966, 15:508-524.
27. Green HJ, Reichmann H, Pette D. Inter- and intraspecies comparisons of fibre type distribution and of succinate dehydrogenase activity in type I, IIA and IIB fibres of mammalian diaphragms. Histochemistry 1984, 81:67-73. 10.1007/BF00495403, 6469723.
28. Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 1999, 277:R601-R606.
29. Sher J, Cardasis C. Skeletal muscle fiber types in the adult mouse. Acta Neurol Scand 1976, 54:45-56. 10.1111/j.1600-0404.1976.tb07619.x, 132838.
30. Bertaggia E, Coletto L, Sandri M. Posttranslational modifications control FoxO3 activity during denervation. Am J Physiol Cell Physiol 2012, 302:C587-C596. 10.1152/ajpcell.00142.2011, 22094330.
31. Lokireddy S, Wijesoma IW, Teng S, Bonala S, Gluckman PD, McFarlane C, Sharma M, Kambadur R. The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metab 2012, 16:613-624. 10.1016/j.cmet.2012.10.005, 23140641.
32. Wei B, Dui W, Liu D, Xing Y, Yuan Z, Ji G. MST1, a key player, in enhancing fast skeletal muscle atrophy. BMC Biol 2013, 11:12. 10.1186/1741-7007-11-12, 3606410, 23374633.
33. Kang J, Jeong MG, Oh S, Jang EJ, Kim HK, Hwang ES. A FoxO1-dependent, but NRF2-independent induction of heme oxygenase-1 during muscle atrophy. FEBS Lett 2014, 588:79-85. 10.1016/j.febslet.2013.11.009, 24269680.
34. Huey KA, Bodine SC. Changes in myosin mRNA and protein expression in denervated rat soleus and tibialis anterior. Eur J Biochem/FEBS 1998, 256:45-50.
35. Loughna PT, Morgan MJ. Passive stretch modulates denervation induced alterations in skeletal muscle myosin heavy chain mRNA levels. Pflugers Arch 1999, 439:52-55. 10.1007/s004240051127, 10651000.
36. Goodman CA, Frey JW, Mabrey DM, Jacobs BL, Lincoln HC, You JS, Hornberger TA. The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol 2011, 589:5485-5501. 3240886, 21946849.
37. Baehr LM, Tunzi M, Bodine SC. Muscle hypertrophy is associated with increases in proteasome activity that is independent of MuRF1 and MAFbx expression. Front Physiol 2014, 5:69. 3930915, 24600408.
38. Argadine HM, Mantilla CB, Zhan WZ, Sieck GC. Intracellular signaling pathways regulating net protein balance following diaphragm muscle denervation. Am J Physiol Cell Physiol 2011, 300:C318-C327. 10.1152/ajpcell.00172.2010, 3043627, 21084642.
39. Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 2009, 185:1083-1095. 10.1083/jcb.200901052, 2711608, 19506036.
40. Moriscot AS, Baptista IL, Bogomolovas J, Witt C, Hirner S, Granzier H, Labeit S. MuRF1 is a muscle fiber-type II associated factor and together with MuRF2 regulates type-II fiber trophicity and maintenance. J Struct Biol 2010, 170:344-353. 10.1016/j.jsb.2010.02.001, 2856802, 20149877.
41. Argadine HM, Hellyer NJ, Mantilla CB, Zhan WZ, Sieck GC. The effect of denervation on protein synthesis and degradation in adult rat diaphragm muscle. J Appl Physiol 2009, 107:438-444. 10.1152/japplphysiol.91247.2008, 2724326, 19520837.
42. Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, Bassel-Duby R, Olson EN. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 2010, 143:35-45. 10.1016/j.cell.2010.09.004, 2982779, 20887891.
43. Macpherson PC, Wang X, Goldman D. Myogenin regulates denervation-dependent muscle atrophy in mouse soleus muscle. J Cell Biochem 2011, 112:2149-2159. 10.1002/jcb.23136, 3135771, 21465538.
44. Duclert A, Piette J, Changeux JP. Influence of innervation of myogenic factors and acetylcholine receptor alpha-subunit mRNAs. Neuroreport 1991, 2:25-28. 10.1097/00001756-199101000-00006, 1768845.
45. Eftimie R, Brenner HR, Buonanno A. Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity. Proc Natl Acad Sci U S A 1991, 88:1349-1353. 10.1073/pnas.88.4.1349, 51015, 1705035.
46. Witzemann V, Sakmann B. Differential regulation of MyoD and myogenin mRNA levels by nerve induced muscle activity. FEBS Lett 1991, 282:259-264. 10.1016/0014-5793(91)80490-T, 1645281.
47. Perera S, Mankoo B, Gautel M. Developmental regulation of MURF E3 ubiquitin ligases in skeletal muscle. J Muscle Res Cell Motil 2012, 33:107-122. 10.1007/s10974-012-9288-7, 3353113, 22426552.
48. Ausoni S, Gorza L, Schiaffino S, Gundersen K, Lomo T. Expression of myosin heavy chain isoforms in stimulated fast and slow rat muscles. J Neurosci Offic J Soc Neurosci 1990, 10:153-160.
49. Schiaffino S, Sandri M, Murgia M. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 2007, 22:269-278. 10.1152/physiol.00009.2007, 17699880.
50. Magnusson C, Hogklint L, Libelius R, Tagerud S. Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle. J Neurosci Res 2001, 66:457-463. 10.1002/jnr.10000, 11746363.
51. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 10.1016/0003-2697(76)90527-3, 942051.
52. Siegel AL, Bledsoe C, Lavin J, Gatti F, Berge J, Millman G, Turin E, Winders WT, Rutter J, Palmeiri B, Carlson CG. Treatment with inhibitors of the NF-kappaB pathway improves whole body tension development in the mdx mouse. Neuromuscular Disord: NMD 2009, 19:131-139.
53. Evertsson K, Fjallstrom AK, Norrby M, Tagerud S. p38 mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 (MK2) signaling in atrophic and hypertrophic denervated mouse skeletal muscle. J Mol Signal 2014, 9:2. 10.1186/1750-2187-9-2, 3995524, 24629011.